The White House released the National HIV/AIDS Strategy 2023 Interim Action Report (PDF, 222KB) on December 1. The report signals that we are making progress toward the goals outlined in the Strategy, but we must continue to support and accelerate our efforts to end the HIV epidemic in the United States.
Excerpts: HRSA Federal Agency Highlights
Goal 1: Prevent New HIV Infections
- CDC, HRSA, IHS, NIH, OASH & SAMHSA: Due, in part, to the efforts of multiple HHS agencies to expand PrEP awareness, availability, and provider capacity, preliminary data indicate that in 2022, for the first time, more than one-third of people in the U.S. who could benefit from PrEP had been prescribed it. Overall, in 2022, 36% of the 1.2 million people who could benefit from PrEP were prescribed it, compared to 23% in 2019, the year that EHE was announced. Further, the preliminary data indicate that in 2022 10 EHE jurisdictions had met or exceeded the 2025 EHE (and NHAS) goal of 50% PrEP coverage. However, while the data show improvement in PrEP prescriptions among all racial/ethnic groups from 2019 to 2022, the reach of this strategy is far from equal, and severe and widening inequities persist. Estimates suggest 94% of White people who could benefit from PrEP have been prescribed it, but only 13% of Black and 24% of Hispanic/Latino people who could benefit have been prescribed PrEP. [Read PrEP Policies and Programs Help End the HIV Epidemic.]
- HRSA’s Bureau of Primary Health Care awarded a total of $157 million in FY 2023 to 411 health centers to support expanded access to HIV testing and prevention services in the 57 EHE jurisdictions. Additionally, nine technical assistance organizations were also funded to support health center PrEP and HIV efforts.
Goal 2: Improve HIV-Related Health Outcomes of People with HIV
- HRSA/HAB-funded services include capacity building and technical assistance by the Technical Assistance Provider-innovation network (TAP-in) and EHE Systems Coordination Provider to ensure that EHE jurisdictions can effectively identify people newly diagnosed with HIV and engage people with HIV who are not in care and/or not virally suppressed.
- The Ryan White HIV/AIDS Program (RWHAP) produced a Best Practices Compilation that includes more than 75 effective innovative interventions.
Goal 3: Reduce HIV-Related Health Disparities and Inequities
- HAB funded 12 clinical and community-based organizations as demonstration sites and one Evaluation and Technical Assistance Provider to adapt, implement, and assess the uptake of evidence-based, bundled interventions to improve health outcomes and well-being for Black women with HIV. The initiative is meant to address psychosocial and medical needs to help reduce inequities in the provision of culturally relevant, women-centered care and to develop tailored community and clinic-based approaches to address intimate partner violence and provide trauma-informed care.
- HAB also funded a special project of national significance (SPNS) to identify, pilot test, and evaluate innovative intervention strategies to improve health outcomes among three priority populations: people with SUD, LGBTQ+ youth, and people who are or have been justice involved. Comprehensive implementation guides for this SPNS will be made publicly available.
- In FY 2023, the HAB awarded $2.4 billion to cities, states, and local clinics/community-based organizations to deliver efficient and effective HIV care, treatment, and support to low-income people with HIV. In 2021, nearly 90% of RWHAP clients who received medical care from RWHAP providers during the year and had at least one viral load test were virally suppressed and disparities among priority populations are narrowing.
- In addition, HRSA, CDC, and HUD hosted a virtual Technical Expert Panel to examine opportunities and barriers to accessing HUD assisted housing (including, but not limited to, the Housing Opportunities for Persons with AIDS [HOPWA] program).